Syncom Formulations (India) Ltd

SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve 1. the Standalone and Consolidated Un-audited Quarter and Nine Months ended Financial Results of the Company for the Quarter and Nine Months ended on 31st December 2022.2. Limited Review Report by the Statutory Auditors for Financial Results of the company for the Quarter and Nine Months ended on 31st December 2022.3. And other Routine Business.